These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36529474)

  • 1. [Medical treatments in Leber's hereditary optic neuropathy].
    Hage R
    J Fr Ophtalmol; 2022 Nov; 45(8S1):S24-S31. PubMed ID: 36529474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leber Hereditary Optic Neuropathy: Review of Treatment and Management.
    Hage R; Vignal-Clermont C
    Front Neurol; 2021; 12():651639. PubMed ID: 34122299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leber's Hereditary Optic Neuropathy as a Promising Disease for Gene Therapy Development.
    Karaarslan C
    Adv Ther; 2019 Dec; 36(12):3299-3307. PubMed ID: 31605306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
    Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
    PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A challenging differential diagnosis - Leber's Hereditary Optic Neuropathy.
    Iorga RE; Munteanu-Dănulescu RS; Danielescu C
    Rom J Ophthalmol; 2024; 68(1):65-71. PubMed ID: 38617721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solutions to a Radical Problem: Overview of Current and Future Treatment Strategies in Leber's Hereditary Opic Neuropathy.
    Spiegel SJ; Sadun AA
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear modifier YARS2 allele correction restored retinal ganglion cells-specific deficiencies in Leber's hereditary optic neuropathy.
    Chen JR; Chen C; Chen J; Ji Y; Lian Y; Zhang J; Yu J; Li XY; Qu J; Guan MX
    Hum Mol Genet; 2023 Apr; 32(9):1539-1551. PubMed ID: 36611011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Past, present, and future in Leber's hereditary optic neuropathy].
    Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):809-27. PubMed ID: 11802455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leber's hereditary optic neuropathy - Case report.
    Iorga RE; Mihailovici R; Ozturk MR; Costin D
    Rom J Ophthalmol; 2018; 62(1):64-71. PubMed ID: 29796436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further advances in the diagnosis and treatment of Leber's Hereditary Optic Neuropathy - a review.
    Tăbăcaru B; Stanca HT
    Rom J Ophthalmol; 2022; 66(1):13-16. PubMed ID: 35531455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leber's Hereditary Optic Neuropathy].
    Priglinger C; Klopstock T; Rudolph G; Priglinger SG
    Klin Monbl Augenheilkd; 2019 Nov; 236(11):1271-1282. PubMed ID: 31639883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy.
    Asanad S; Tian JJ; Frousiakis S; Jiang JP; Kogachi K; Felix CM; Fatemeh D; Irvine AG; Ter-Zakarian A; Falavarjani KG; Barboni P; Karanjia R; Sadun AA
    Curr Eye Res; 2019 Jun; 44(6):638-644. PubMed ID: 30649972
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
    Pemp B; Kircher K; Reitner A
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber's hereditary optic neuropathy.
    Nie Z; Wang C; Chen J; Ji Y; Zhang H; Zhao F; Zhou X; Guan MX
    Hum Mol Genet; 2023 Jan; 32(2):231-243. PubMed ID: 35947995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid onset of visual recovery following acute visual loss due to leber's hereditary optic neuropathy].
    Kawasaki A; Borruat FX
    Rev Neurol (Paris); 2005 May; 161(5):599-601. PubMed ID: 16106816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Leber's hereditary optic neuropathy: An overview of recent developments.
    Zuccarelli M; Vella-Szijj J; Serracino-Inglott A; Borg JJ
    Eur J Ophthalmol; 2020 Nov; 30(6):1220-1227. PubMed ID: 32552047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.
    Bahr T; Welburn K; Donnelly J; Bai Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165743. PubMed ID: 32105823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
    Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
    Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three Cases of Leber's Hereditary Optic Neuropathy with Rapid Increase in Visual Acuity After Gene Therapy.
    Zhang Y; Yuan JJ; Liu HL; Tian Z; Liu SW; Li B
    Curr Gene Ther; 2019; 19(2):134-138. PubMed ID: 31237206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitophagy activation repairs Leber's hereditary optic neuropathy-associated mitochondrial dysfunction and improves cell survival.
    Sharma LK; Tiwari M; Rai NK; Bai Y
    Hum Mol Genet; 2019 Feb; 28(3):422-433. PubMed ID: 30304398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.